ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 77

Human Mesenchymal Stem Cells Cultured On Collagen Scaffolds For Cartilage Tissue Engineering

Clara Sanjurjo-Rodríguez1, Adela Helvia Martínez-Sánchez2, Tamara Hermida-Gómez1, Isaac M. Fuentes-Boquete1,2, Francisco J. De Toro2,3, Julia Buján4, Silvia Díaz-Prado2,3 and Francisco J. Blanco2, 1Grupo de Bioingeniería Tisular y Terapia Celular (CBTTC-CHUAC). CIBER-BBN/ISCIII. Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de Coruña (CHUAC). SERGAS. Universidade de A Coruña, A Coruña, Spain, 2Osteoarticular and Aging Res. Lab. CIBER-BBN. INIBIC- University of A Coruña, A Coruña, Spain, 3INIBIC-Universidade da Coruña, A Coruña, Spain, 4University of Alcalá de Henares, Department of Medical Specialties, Madrid, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cartilage, Collagen, mesenchymal stem cells and tissue engineering

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint (Cartilage and Osteoarthritis)

Session Type: Abstract Submissions (ACR)

 

 

Background/Purpose: Osteoarthritis is a degenerative disease without a treatment. Tissue Engineering could provide an alternative tool for cartilage repair. The aim of this study was to evaluate the neotissue formed using human bone marrow mesenchymal stem cells (hBM-MSCs) and collagen scaffolds.

Methods: hBM-MSCs were cultured on collagen (Col), Col+heparan sulfate (HS), Col+chondroitin sulfate (CHS) and Col+heparin (OLH3) scaffolds, in chondrogenic medium supplemented by TGFβ-3. Chondrogenic differentiation and the constructs were evaluated by histochemistry, immunohistochemistry, and molecular biology. Cellular morphology and ultrastructure were studied by electron microscopy. Culture supernatants were collected and the amount of secreted collagen was measured by ELISA.

Results: Haematoxilin-Eosin staining showed that hBM-MSCs have grown through the scaffolds. The cellular percentage respect the whole scaffold area was higher than 50% in all the biomaterials and it was observed a big amount of extracellular matrix (ECM) in all of them, except in Col+OLH3. The ECM showed proteoglycans, by means of safranin O (SO) staining, and immunopositivity for Col II in all the constructs, except in Col+OLH3 (Figure). By measurement of relative expression levels (REL) we observed that COLII were expressed by cells in Col I (0.63), Col I+Col II (1.00), Col I+3%HS (0.47), Col I+Col II+HS (0.93), Col I+Col II+CHS (3.57) and Col I+OLH3 (5.20). Moreover, REL of AGG were higher in Col I+Col II+HS (6.47) constructs than  in Col I (0.00), Col I+Col II (0.95),Col I+3%HS (0.17), Col I+Col II+CHS (0.00) and Col I+OLH3 (0.00). Electron microscopy showed cells with a big amount of mitochondria and with spherical and oval shapes (Figure). Col released was detected in all supernatant cultures, obtaining the highest concentration (μg/total volume) at all times, in Col I+3%HS cultures except at day 21: Col I (137.33), Col I+Col II+HS (3.33), Col I+Col II (0.00),Col I+3%HS (0.00), Col I+Col II+CHS (13.90) and Col I+OLH3 (0.00) .

Conclusion: Data showed that hBM-MSCs are capable of growing on collagen scaffolds. On HS enriched collagen scaffolds was kept the differentiated phenotype. The ECM characteristics and the gene expression showed the synthesis of a cartilage-like neotissue which could be useful for cartilage tissue engineering. Acknowledgements: Opocrin S.P.A.; CAM (S2009/MAT-1472); CIBER-BBN CB06-01-0040; SAI-UDC; REDICENT; Diputación de A Coruña; Jiménez Díaz Fundation.


Disclosure:

C. Sanjurjo-Rodríguez,
None;

A. H. Martínez-Sánchez,
None;

T. Hermida-Gómez,
None;

I. M. Fuentes-Boquete,
None;

F. J. De Toro,
None;

J. Buján,
None;

S. Díaz-Prado,
None;

F. J. Blanco,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/human-mesenchymal-stem-cells-cultured-on-collagen-scaffolds-for-cartilage-tissue-engineering/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology